Zentalis Pharmaceuticals (ZNTL) PT Lowered to $2 at Leerink Partners
Tweet Send to a Friend
Leerink Partners analyst Andrew Berens lowered the price target on Zentalis Pharmaceuticals (NASDAQ: ZNTL) to $2.00 (from $5.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
